Management of Benign CBD Stricture
Endoscopic therapy with temporary placement of multiple plastic stents over a prolonged period is the first-line treatment for benign CBD strictures, achieving success rates of 74-90%, though recurrence occurs in up to 30% of patients within 2 years of stent removal. 1
Etiology: Can a Passed Stone Cause Stricture?
Yes, a passed stone can absolutely cause benign CBD stricture through several mechanisms:
- Stone-related trauma: Stones can cause direct injury to the bile duct wall during passage, leading to inflammation, fibrosis, and subsequent stricture formation 2, 3
- Perforation and inflammation: Stone perforation through the duct wall triggers intense inflammatory response and scarring 3
- Chronic obstruction: Long-standing stones cause upstream inflammation and fibrosis even after passage 2
- Secondary biliary cirrhosis: Untreated or recurrent stone-related strictures can progress to secondary biliary cirrhosis if left unmanaged 2
Initial Diagnostic Approach
Trans-abdominal ultrasound and liver function tests are recommended as initial evaluation, but normal results do not exclude stricture if clinical suspicion remains high. 1
- Look specifically for: biliary dilation, wall thickening, jaundice, elevated alkaline phosphatase and bilirubin 1, 4
- Advanced imaging with MRCP or EUS is indicated when initial tests are inconclusive but suspicion persists 1, 5
- ERCP provides both diagnostic visualization and therapeutic intervention 1
First-Line Endoscopic Management
Multiple plastic stent placement is the preferred initial treatment strategy:
- Stent protocol: Place multiple plastic stents (typically 2-4) to maximize dilation of the stricture 1
- Duration: Stents remain in place for 4-8 weeks initially, with serial exchanges every 3 months 1
- Total treatment duration: Continue stenting for 12 months or longer to achieve optimal long-term patency 1
- Success rates: 74-90% initial success, but 30% recurrence within 2 years after stent removal 1
For strictures >2 cm from the hepatic confluence, fully covered self-expanding metal stents (SEMS) are an alternative to plastic stents. 1
When Strictures Are Recognized Early
- Early post-injury strictures (recognized within weeks of the inciting event) respond more favorably to endoscopic treatment than delayed fibrotic strictures 1
- These are often associated with bile leak and respond better because fibrosis is less established 1
- Aggressive early treatment prevents progression to dense fibrotic strictures 1
Follow-Up Protocol
Structured surveillance is essential given the 30% recurrence rate:
- During stenting: ERCP with cholangiography every 3 months for stent exchange 1
- After stent removal: Repeat cholangiography at stent removal to confirm resolution 1
- Post-treatment surveillance: Monitor liver function tests every 3-6 months for the first 2 years 1
- Clinical monitoring: Watch for recurrent symptoms (jaundice, cholangitis, right upper quadrant pain) that suggest re-stricturing 4
- Imaging if symptomatic: Obtain MRCP or repeat ERCP if liver enzymes rise or symptoms recur 1, 5
Alternative Approaches When ERCP Fails
Percutaneous transhepatic biliary drainage (PTBD) is the next option when endoscopic access fails:
- Technical success rate of 90% in expert centers 1
- Short-term clinical success of 70-80% 1
- Particularly useful for complete obstructions with sepsis 1
- Can be more difficult with non-dilated ducts but still achievable 1
Surgical Management
Surgery is reserved for endoscopic failures or complex strictures:
- Roux-en-Y hepaticojejunostomy is the definitive surgical repair for refractory strictures 1
- Referral to a hepatobiliary surgeon is essential—non-specialist repairs have higher failure rates 1
- Surgical repair shows superior 5-year outcomes when performed by experienced HPB surgeons 1
Critical Pitfalls to Avoid
- Don't stop surveillance after stent removal: The 30% recurrence rate within 2 years means ongoing monitoring is mandatory 1
- Don't delay treatment: Untreated strictures can progress to secondary biliary cirrhosis and liver failure 2
- Don't attempt surgical repair without HPB expertise: Non-specialist repairs have significantly higher morbidity and mortality 1
- Don't assume normal LFTs exclude stricture: Maintain high clinical suspicion even with normal labs if symptoms suggest biliary obstruction 1, 4
- Don't use stenting as definitive treatment in young, healthy patients: Consider surgical repair for better long-term outcomes in appropriate candidates 1